Sandbox Reserved 1095: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Modification of the title, correction of some orthography mistakes in the part "History", adding a sentence in the part "application in the therapeutic field", detail the part structure (draft) |
No edit summary |
||
| Line 8: | Line 8: | ||
Searchers suspected since 70s the existence of different angiotensin receptors. But it was only at the end of 80s that searchers had tools to identify these two distinct trans-membrane receptors (AT1R and AT2R)<ref> </ref>. Three labs discovered in the same time these two receptors so they were some confusion about the nomenclature. So in 1991 a group of searchers met to define a coherent nomenclature. ''Finally, around 2015, researchers the crystal structure of the receptor in complex with its antagonist ZD7155 and with an inverse agonist olmesartan'' <ref> </ref>. They used x-ray cryogenic-crystallography. They found similar conformation of the receptor when it is linked to the antagonist or to the inverse agonist. They also found conserved molecular recognition modes. So to complete the discovery, they realized some experiments with mutants to identify the different residues which interact with the ligand. | Searchers suspected since 70s the existence of different angiotensin receptors. But it was only at the end of 80s that searchers had tools to identify these two distinct trans-membrane receptors (AT1R and AT2R)<ref> </ref>. Three labs discovered in the same time these two receptors so they were some confusion about the nomenclature. So in 1991 a group of searchers met to define a coherent nomenclature. ''Finally, around 2015, researchers the crystal structure of the receptor in complex with its antagonist ZD7155 and with an inverse agonist olmesartan'' <ref> </ref>. They used x-ray cryogenic-crystallography. They found similar conformation of the receptor when it is linked to the antagonist or to the inverse agonist. They also found conserved molecular recognition modes. So to complete the discovery, they realized some experiments with mutants to identify the different residues which interact with the ligand. | ||
== Structure | == Structure (function relationship) == | ||
=== Primary and secondary structure === | === Primary and secondary structure === | ||
376 amino acids | 376 amino acids <ref> http://www.ebi.ac.uk/thornton-srv/databases/cgi-bin/pdbsum/GetPage.pl </ref> | ||
=== Ligand binding pocket === | |||
== Application in the therapeutic field == | == Application in the therapeutic field == | ||
Since angiotensin receptor is involved in the renin-angiotenisin system, it represents a choice | Since angiotensin receptor is involved in the renin-angiotenisin system, it represents a target of choice to cure some diseases like hypertension or heart failure. | ||
| Line 22: | Line 24: | ||
== References == | == References == | ||
<references/> | <references/> | ||
This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes. | This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes. | ||
